Molecular LogiX  A rational way to create new drugs

company

innovation

management

information

home

Text Box: Molecular LogiX We are in the business of creating new drug leads.  Utilizing our proprietary protein "re-engineering" capabilities, Molecular LogiX can evaluate specific modifications of clinically-relevant proteins to create new therapeutic properties. Our efforts are focused on the development of new "Dominant Negative Ligands" for the treatment of important diseases. Our primary work is devoted to the development of a new "Pan-HER Anti-Cancer Ligand" to treat tumors that have become resistant to current molecular targeting therapies.                         

Text Box: 4200 Research Forest Drive Suite 120    |    The Woodlands, TX 77381    |    Phone: 281-298-9280